ARCHIVES

White House Yet To Name NCAB, Cancer Panel Members

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

GAO Report Finds Increase in Self-Referred Pathology Services

August 9, 2013

In Brief: HHS Won’t Nominate Fischbach for NIH; Kirschstein in Charge

April 28, 2000

NCI Programs to Average Eight Percent Increase Over ’87 Under House Total, Bit Some Would Vary

August 14, 1987

Funding Opportunities

April 26, 2002